Stock search

Ticker or company name

Compare stocks

Market: US

  • BSXBoston Scientific
  • CAHCardinal Health
  • EWEdwards Lifesciences

Add stock

Ticker or company

Summary

BSX
Boston Scientific
$43,69Down −1,47%
Year: Down −58%
83/100Best scoreRatio would consider buying
Open stock page
CAH
Cardinal Health
$283,85Up +0,98%
Year: Up +36%

Not enough data for a score

Open stock page
EW
Edwards Lifesciences
$107,11Down −0,04%
Year: Up +24%
56/100Ratio would watch
Open stock page

Verdict

BSX has the best score (83). EW grows revenue the fastest. BSX is the cheapest by forward P/E. EW has the lowest debt load. BSX has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckBSX6 ✓ 3 — 0 ✕CAH1 ✓ 0 — 2 ✕EW5 ✓ 0 — 4 ✕
P/E vs its history18,435,760,3
P/E vs industry18,435,760,3
Forward P/E14,019,235,5
Revenue growth, YoY+8,9%n/a—+13,4%
EPS growth, YoY+26,2%n/a—−23,7%
Net margin16,6%n/a—15,2%
Net debt / EBITDA−0,1n/a—−2,5
Free cash flow$3,33 bnn/a—$1,42 bn
Share count over a year−2,9%n/a—−1,4%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterBSXTTMCAHTTMEWTTMIndustry medianTTM
P/E TTM ↓Best: 18,435,7Worst: 60,325,1
Forward P/E ↓Best: 14,019,2Worst: 35,516,2
PEG ↓Best: 0,7Worst: 3,1n/a2,2
P/S TTM ↓3,1Best: 0,3Worst: 9,22,2
EV/EBITDA ↓Best: 15,623,2Worst: 43,817,3
P/FCF ↓19,3Best: 13,3Worst: 42,619,5

Price, %

  • BSXn/a
  • CAHn/a
  • EWn/a

Returns

Best WorstNo mark — in between

PeriodBSXCAHEW
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

BSXCAHEW
Share of “buy”Worst: 65%Best: 86%82%
Beat the forecastBest: 4 of 4Best: 4 of 4Worst: 3 of 4
Average “surprise”+1,5%Best: +9,5%Worst: +0,7%
Insiders over 12 monthssales $6,76 msales $61,6 msales $34,0 m

Details are on each stock page.